Neurocrine Biosciences, Inc. today announced the initiation of a Phase 3 registrational program to evaluate the efficacy, safety and tolerability of NBI-1117568, the company's investigational oral ...

Engine Biosciences (Engine), a company pioneering cancer medicines informed by its proprietary machine learning and ...

The Incucyte ® Live-Cell Analysis System is a fully automated platform for phase contrast and two-color fluorescence imaging, ...

The two reports, which run hundreds of pages, come at a difficult time for the university, which is suing the Trump ...

Applications for Season 7 are open to women owning at least 50% of a registered Ugandan business across sectors like ...